Market open
Codexis/$CDXS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Codexis
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
Ticker
$CDXS
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
188
Website
Codexis Metrics
BasicAdvanced
$226M
-
-$0.89
2.12
-
Price and volume
Market cap
$226M
Beta
2.12
52-week high
$6.01
52-week low
$2.47
Average daily volume
884K
Financial strength
Current ratio
4.177
Quick ratio
3.905
Long term debt to equity
85.269
Total debt to equity
89.493
Interest coverage (TTM)
-16.72%
Management effectiveness
Return on assets (TTM)
-25.54%
Return on equity (TTM)
-85.03%
Valuation
Price to revenue (TTM)
3.377
Price to book
3.34
Price to tangible book (TTM)
3.47
Price to free cash flow (TTM)
-3.731
Growth
Revenue change (TTM)
-15.39%
Earnings per share change (TTM)
-20.54%
3-year revenue growth (CAGR)
-17.26%
3-year earnings per share growth (CAGR)
39.22%
What the Analysts think about Codexis
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Codexis stock.
Codexis Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Codexis Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Codexis News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Codexis stock?
Codexis (CDXS) has a market cap of $226M as of March 19, 2025.
What is the P/E ratio for Codexis stock?
The price to earnings (P/E) ratio for Codexis (CDXS) stock is 0 as of March 19, 2025.
Does Codexis stock pay dividends?
No, Codexis (CDXS) stock does not pay dividends to its shareholders as of March 19, 2025.
When is the next Codexis dividend payment date?
Codexis (CDXS) stock does not pay dividends to its shareholders.
What is the beta indicator for Codexis?
Codexis (CDXS) has a beta rating of 2.12. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.